Acellular Tissue Engineered Vessel (ATEV): Clinical Trials

1 trial of Acellular Tissue Engineered Vessel (ATEV), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow Acellular Tissue Engineered Vessel (ATEV): new trials by email Literature Review of Acellular Tissue Engineered Vessel (ATEV) trials Research Report on Acellular Tissue Engineered Vessel (ATEV)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Humacyte Acellular Tissue Engineered Vessel (ATEV) in Patients With Vascular Trauma
Acellular Tissue Engineered Vessel (ATEV) - Trauma, Vascular System Injury
Phase 2 / Phase 3CompletedHumacyte, Inc.722018-09-012026-07-29

Conditions studied

Vascular System Injuries (1)  ·  Wounds and Injuries (1)

Sponsors

Humacyte, Inc. (1)

Countries

Israel (1)  ·  United States (1)

Top investigators

Shamik Parikh, MD (1)

Results publications

PMID 39565635, PMID 41140335